Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

68Ga-DOTATOC PET for the Evaluation of Gastroenteropancreatic Neuroendocrine Tumours

NCT06155318 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT06155318
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06155318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
68Ga-DOTATOC PET for the Evaluation of Gastroenteropancreatic Neuroendocrine Tumours
Lead sponsor
IRCCS San Raffaele
Phase
Observational
Overall status
Recruiting
Start date
September 5, 2019
Completion date
May 5, 2029
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastroenteropancreatic neuroendocrine tumor